PCK 6.67% 2.8¢ painchek ltd

Ann: ePAT and PainChek continue to achieve commercial milestones, page-23

  1. 2,702 Posts.
    lightbulb Created with Sketch. 504
    We now have a strong pipeline of leads across large, medium and small RAC providers that we are working on to convert into new commercial sales” added Daffas.

    We may not be making millions in the medium term but the foundations for a international product with no competitors are being poured...
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.